Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in MYGN — Myriad Genetics Inc

CIK 861177 NEW YORK, NY

Position in MYGN

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,051,865
-$326,548 QoQ
Shares Held
233,748
+4.3% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 54% Shared 0% None 46%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,969,794,403 across 32 Diagnostics & Research names. MYGN ranks #28 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,051,865 233,748
2025-12-31 $1,378,413 224,133
2025-09-30 $1,452,308 200,873
2025-06-30 $1,994,405 375,595
2025-03-31 $2,654,397 299,256
2024-12-31 $3,910,486 285,229
2024-09-30 $5,430,230 198,256
2024-06-30 $4,398,148 179,810
2024-03-31 $1,990,668 93,371
2023-12-31 $1,787,119 93,371
2023-09-30 $1,497,667 93,371
2023-06-30 $2,002,912 86,407
2023-03-31 $2,007,232 86,407
2022-12-31 $1,047,794 72,212
2022-09-30 $1,426,380 74,758
2022-06-30 $1,396,908 76,880
2022-03-31 $2,707,158 107,427
2021-12-31 $2,971,304 107,656
2021-09-30 $3,606,047 111,677
2021-06-30 $3,054,633 99,890
2021-03-31 $2,460,602 80,808
2020-12-31 $1,521,299 76,950
2020-09-30 $1,041,034 79,834
2020-06-30 $905,316 79,834
2020-03-31 $1,341,946 93,777